Cargando…
Acute Myeloid Leukemia Cells Harboring MLL Fusion Genes or with the Acute Promyelocytic Leukemia Phenotype Are Sensitive to the Bcl-2-selective Inhibitor ABT-199
Autores principales: | Niu, Xiaojia, Wang, Guan, Wang, Yue, Caldwell, J. Timothy, Edwards, Holly, Xie, Chengzhi, Taub, Jeffrey W., Li, Chunhuai, Lin, Hai, Ge, Yubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090260/ https://www.ncbi.nlm.nih.gov/pubmed/24531733 http://dx.doi.org/10.1038/leu.2014.72 |
Ejemplares similares
-
Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
por: Zhao, Jianyun, et al.
Publicado: (2016) -
Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
por: Luedtke, Daniel A, et al.
Publicado: (2017) -
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
por: Benito, Juliana M., et al.
Publicado: (2015) -
CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
por: Qi, Wenxiu, et al.
Publicado: (2014) -
Targeting MCL-1/BCL-X(L) Forestalls the Acquisition of Resistance to ABT-199
in Acute Myeloid Leukemia
por: Lin, Kevin H., et al.
Publicado: (2016)